Trial record 1 of 1 for:
NCT00720668
The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular Carcinoma (HBV-HCC)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2009 by Sun Yat-sen University.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
Sun Yat-sen University
Information provided by:
Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT00720668
First received: July 21, 2008
Last updated: February 6, 2009
Last verified: February 2009
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | May 2010 |
| Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
Publications:
Bruix J,Sherman M. Management of hepatocellular carcinoma. Hepatology 42(5):1208-1236,2005.